Genetic and Pharmacologic Inhibition of β-Catenin Targets Imatinib-Resistant Leukemia Stem Cells in CML

Overview of attention for article published in Cell Stem Cell, April 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

blogs: 1 blog
twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 207 Dimensions

Readers on

mendeley: 155 Mendeley
citeulike: 2 CiteULike

Summary Blogs X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors

Grant US-9624218-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.